This HTML5 document contains 131 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q48169359
rdf:type
wikibase:Item
schema:description
مقالة علمية bilimsel makale article scientifique (publié 1998) tieteellinen artikkeli articolo scientifico 1998年学术文章 scientific article 1998 nî lūn-bûn article científic 1998年學術文章 επιστημονικό άρθρο scienca artikolo bài báo khoa học tudományos cikk vitskapeleg artikkel naučni članak article scientific videnskabelig artikel (udgivet 1998) 1998年学术文章 artículo científico publicado en 1998 teaduslik artikkel мақолаи илмӣ 1998年学术文章 სამეცნიერო სტატია artigo científico мақолаи илмӣ artykuł naukowy 1998年學術文章 artikull shkencor vetenskaplig artikel 1998年學術文章 1998年学术文章 mokslinis straipsnis научна статия artigo científico (publicado na 1998) vitenskapelig artikkel наукова стаття, опублікована в жовтні 1998 บทความทางวิทยาศาสตร์ գիտական հոդված ১৯৯৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак vedecký článok articol științific vědecký článek 1998年學術文章 artigo científico (publicado na 1998) 1998年学术文章 artículu científicu 1998年の論文 wissenschaftlicher Artikel 1998年學術文章 1998년 논문 مقالهٔ علمی artikulong pang-agham научная статья מאמר מדעי научни чланак wetenschappelijk artikel سائنسی مضمون 1998年學術文章
p:P577
wds:Q48169359-AB075794-9E28-4B3A-8816-45BAEC655667
wdt:P577
1998-10-01T00:00:00Z
p:P407
wds:Q48169359-7BBB192C-18A4-4A24-A136-51455C04AA8C
wdt:P407
wd:Q1860
p:P2860
wds:Q48169359-13DD3C59-BD88-4252-BA38-4B4171A941AF wds:Q48169359-3143F63D-17D5-4BC1-8B55-B3735972CF96 wds:Q48169359-9C58B5EC-AA20-481B-8425-70256CAD6F61 wds:Q48169359-9E412B88-4F58-424E-B9B8-AB6354FE9260 wds:Q48169359-A7478EE6-EBA1-495E-9685-9B8A14AC8F4C wds:Q48169359-B51A32F6-5152-498C-A3E8-355F3332C33D wds:Q48169359-509FF565-AB5E-4ADC-B3F1-1421A020FD65 wds:Q48169359-699030C2-0610-4547-9509-7195CBD49EDB wds:Q48169359-6E6DDFA9-BFCE-4CBC-A6FA-8031588E668A wds:Q48169359-748C1F75-1347-4DD8-927C-81662226D786 wds:Q48169359-947A12DC-DD15-4919-B5DC-8751E3A34FE3 wds:Q48169359-C16E6825-5A4C-48C1-A7EB-2DC80DDE259C wds:Q48169359-CA0C3A14-3431-41F2-B5FA-71B01488375F wds:Q48169359-D35DFBC4-8954-4844-8497-A21DD49269DD
wdt:P2860
wd:Q48975121 wd:Q24315230 wd:Q33768464 wd:Q36446250 wd:Q68140356 wd:Q39796971 wd:Q70114801 wd:Q72052206 wd:Q44405136 wd:Q69939885 wd:Q72393658 wd:Q48789449 wd:Q71815056 wd:Q70442586
p:P2093
wds:Q48169359-C0FFF4D4-8988-4144-AE6B-83384AC64445 wds:Q48169359-963F5DC3-06AE-4BBC-9CC0-93737D3A7234 wds:Q48169359-993B156E-B92C-4EE5-AA9D-ECB9D606C4D7 wds:Q48169359-729BFD17-78F4-4E9B-89C3-ED0E80AC25C7 wds:Q48169359-4AB8AADE-CA03-475B-9F9C-25F688EA8CED wds:Q48169359-19931993-0466-491F-8FB9-1F8F040E03F3 wds:Q48169359-D4D29973-133D-4FD1-ADC9-E2A903AA85B2
wdt:P2093
Shinoda J Nishimura Y Sakai N Murase S Takami T Takenaka K Saio M
rdfs:label
Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
skos:prefLabel
Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
schema:name
Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
p:P1476
wds:Q48169359-A8C19A8F-CFE4-446B-A801-048A712E84B4
wdt:P1476
Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
p:P304
wds:Q48169359-5A7B01D2-1A80-48B8-8428-5356F6397D4D
wdt:P304
181-186
p:P31
wds:Q48169359-354F4036-1503-4534-9491-6B1717B758AC
wdt:P31
wd:Q13442814
p:P698
wds:Q48169359-22E29672-C6A6-4CD0-8C4B-1D6DCD89CFA3
wdtn:P698
n12:10397472
wdt:P698
10397472
p:P1433
wds:Q48169359-13A69FB9-1549-4D8A-B642-0268F8FF9E35
wdt:P1433
wd:Q326372
p:P433
wds:Q48169359-4A19D7AF-C555-4543-8E8B-062EDDED1D59
p:P478
wds:Q48169359-B8EF570F-AD8A-440D-B8F7-9A18E881CC04
wdt:P433
1-2
wdt:P478
132
p:P356
wds:Q48169359-3753521E-5B65-4229-8DE9-0051B910CB28
wdtn:P356
n11:S0304-3835(98)00181-5
wdt:P356
10.1016/S0304-3835(98)00181-5